We next transfected purified CD4+ lymphocytes, which represent the most typical tumor phenotype in ALK+ ALCL, and were able to express active NPM-ALK protein as early as 6 days post-transfection (Fig. 2A). The gene discussed is CD4; the disease is anaplastic large cell lymphoma.